Page 21 - Riverwater 2020 Sustainability Report

2020 SUSTAINABILITY REPORT
APPENDIX A: COVID EFFORTS OF RIVERWATER COMPANIES
APPENDIX A
COVID EFFORTS OF RIVERWATER COMPANIES
1. Quest Diagnostics provided testing in 12 laboratories and performed more than 400,000 tests per day, handling 20% of testing efforts across the country.
2. Electromed started a Pathfinder Open project developing a technology to detect COVID and help with vaccine research.
3. Corning donated thousands of microplates that are used in labs to screen drug compounds to expedite the discovery of drugs that might be effective in treated COVID and substantially expanded its production to manufacture glass vials to house vaccines.
4. GlaxoSmithKline used adjuvant technology in vaccines to boost the body’s immune response and to require less of the vaccine to be effective and is working with CureVac to develop next generation mRNA vaccines, as well as support the manufacture of up to 100 million doses of CureVac’s first generation vaccine candidate CVnCoV in 2021.
5. Harvard Biosciences expanded support for contract research organizations, researchers in government, academic, and pharmaceutical labs to develop treatments and vaccines.
6. Hologic launched its new Aptima molecular assay to detect the SARS-CoV-2 virus that runs on its market-leading Panther system and offered COVID-19 testing to all 50 states to deliver more than 10 million tests to lab partners each month.
7. Kindred Biosciences expanded an agreement with Vaxart, Inc. for the manufacture of Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.
8. Pfizer developed the widest available COVID-19 vaccine with BioNTech and will supply a total of 300 million doses to the world over the next year and a half.
9. Quidel opened a new facility and hired 400 new employees to produce up to 600mm QuickVue SARS rapid antigen test per year to detect and diagnose COVID-19 infections.
10. Redhill Biopharma is working with regulatory authorities and the scientific community to evaluate the potential of its two investigational new drugs: Opaganib and RHB-107 to treat COVID-19 patients.
11. Thermo Fisher Scientific launched a CE-IVD-Marked high-throughput solution that enables clinical and public health laboratories to efficiently test up to 8,000 COVID-19 samples a day with fewer staffing requirements and designed and developed a control as a synthetic RNA, non-infectious control to help labs validate and monitor COVID-19 molecular diagnostic tests.
12. Meridian Biosciences created a range of COVID-19 testing solutions for both molecular and immunoassay technologies, including optimized RT-qPCR mixes ideal for fast and accurate testing and high performing recombinant antigens for IgG and/or Igm testing and its products are used in over 100 approved COVID-19 related assays around the world.
13. Zebra Technologies provided significant technology expertise to aid in the distribution and administration of COVID vaccines. It also provided mobile computers used by nurses to arrange virtual visits between patients and their loved ones.
21